Preferred Label : lucentis;

UMLS semantic type : T116 - Amino Acid, Peptide, or Protein; T121 - Pharmacologic Substance; T129 - Immunologic Factor;

Is substance : O;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3165902/fr/lucentis
2020
false
false
false
France
insurance, health, reimbursement
infant, premature
intravitreal injections
retinopathy of prematurity
vascular endothelial growth factor a
ranibizumab
evaluation of the transparency committee
Ranibizumab
lucentis
Ranibizumab

---
https://www.has-sante.fr/portail/jcms/c_2876136/fr/lucentis
2018
false
false
false
France
Ranibizumab
treatment outcome
ranibizumab
evaluation of the transparency committee
lucentis

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.